3-D conformal radiation therapy in upper gastrointestinal cancer. The University of Michigan experience.
Lawrence
T S
TS
University of Michigan Medical Center, Department of Radiation Oncology, Ann Arbor, USA.
Kessler
M L
ML
Robertson
J M
JM
D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001650:Bile Duct Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D001973:Bromodeoxyuridine / Q000627:therapeutic use; D005770:Gastrointestinal Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008113:Liver Neoplasms / Q000532:radiotherapy* / Q000556:secondary; D008824:Michigan; D011838:Radiation-Sensitizing Agents / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D012074:Remission Induction; D015996:Survival Rate; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D011838:Radiation-Sensitizing Agents; D001973:Bromodeoxyuridine